HOW IS MISKAWAAN CHELATION THERAPY PERFORMED?
Before embarking on chelation therapy at Miskawaan, a comprehensive assessment is conducted. This includes an analysis of a patient’s blood cells, metabolic processes, kidney function, and liver health. Such scrutiny ensures that the treatment poses no unwarranted risks.
Subsequently, a low-level chelating agent is introduced into the patient’s system to mobilize heavy metals, directing them into the urine. This initial stage allows for the determination of the “body burden,” a reflection of the accumulated heavy metals.
EDTA is then administered intravenously, with supplemental oral treatments interspersed between infusion sessions. The frequency and duration of chelation sessions are tailored to the patient’s body burden, with sessions typically lasting two hours and occurring up to three times weekly. The duration of therapy varies based on individual heavy metal levels but may span several months.
Throughout the process, urine tests are periodically conducted to gauge the success of chelation in binding to and excreting heavy metals. Additionally, a mineral infusion follows each chelation session, replenishing essential minerals, such as magnesium, potassium, and selenium, that are chelated from the body alongside heavy metals.
Chelation therapy is seamlessly integrated into our comprehensive cancer and post-cancer treatment plans at Miskawaan.